CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ipsen Biopharmaceuticals, an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), announced today that the United States Food and Drug Administration (FDA) has approved a ...

7 October 2013 - Newcastle: Aesica, the global contract development and manufacturing organisation (CDMO), has extended its aseptic capabilities at its Nottingham site with the acquisition of new ...

WUXI, China, June 5, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product ...

NEWARK, Del.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (“Gore”), a global materials science company, recently announced the commercial launch of the 0.5 mL silicone-free* GORE® IMPROJECT® ...

WuXi Biologics, a CDMO, launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi ...

Novartis announces the launch in Europe of the Lucentis pre-filled syringe (PFS), which is specifically designed for intraocular injection The Lucentis PFS can lead to improved patient treatment via a ...

Please provide your email address to receive an email when new articles are posted on . The prefilled syringe is indicated for wet age-related macular degeneration, diabetic macular edema and retinal ...

MedPro Safety Products has introduced a pre-filled safety syringe. The device contains a precise dose of pharmaceutical stored within a syringe system. The product also is equipped with a passive ...

Genentech announced that the Food and Drug Administration (FDA) has approved Lucentis (ranibizumab injection) 0.5mg pre-filled syringe (PFS) as a new method of administration to treat both wet ...

POMONA, Calif., Feb. 3, 2026 /PRNewswire/ -- Amsino International, Inc. is pleased to announce a new three-year partnership with Partners Cooperative, effective January 1, 2026. This agreement ...

Says purchase price includes debt Says acquisition to add to earnings in first year Says Hyaluron forecast 2010 rev of $15mln-$17mln June 15 (Reuters) - Albany Molecular Research Inc said it acquired ...

Amsino International, Inc. is a global medical device manufacturer and supplier focused on delivering high-quality, reliable products to healthcare providers. With a strong emphasis on innovation, ...